MoonLake Immunotherapeutics

NASDAQ:MLTX

38.55 (USD) • At close March 14, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q4
Assets:
Current Assets:
Cash & Cash Equivalents 180.426375.656342.791458.441451.169318.166501.78750.12939.50641.20592.708101.0238.0391.0291.0981.170
Short Term Investments 267,600.9118.268177.00888.61459.839177.813012.92132.60942.25500000115.0150
Cash and Short Term Investments 448,027.349493.925519.8547.055511.008495.979501.78763.0572.11583.45992.708101.0238.0391.0291.0981.170
Net Receivables 2.8432.4071.6771.4961.0570.7210.620.3780.2170.6010.557150.1490000
Inventory 00000000000000000
Other Current Assets 23,418.29815.98415.4065.0392.1023.313.963.0764.1794.4790.0780.1360.1270.0440.2340.290
Total Current Assets 474,288.845512.316536.882553.59514.167500.01506.36766.50476.51188.53998.378116.1599.6371.2071.3311.460
Non-Current Assets:
Property, Plant & Equipment, Net 3.6443.8333.8674.2083.9490.2090.2540.2920.3320.0530.0560.0590.0460.03000
Goodwill 00000000000000000
Intangible Assets 00000000000000000
Goodwill and Intangible Assets 00000000000000000
Long Term Investments 00000000000115.051115.043115.04115.039115.0330
Tax Assets 00000000000000000
Other Non-Current Assets 3,640.7932.0654.1296.3198.423000000-0.059-115.043-0.03000
Total Non-Current Assets 3,644.4375.8977.99610.52712.3730.2090.2540.2920.3320.0530.056115.0510.046115.04115.039115.0330
Total Assets 477,933.282518.213544.878564.117526.54500.219506.62166.79776.84388.59298.434231.219.682116.247116.37116.4920
Liabilities & Equity:
Current Liabilities:
Account Payables 8.6780.1040.0561.630.5530.8240.2710.5110.0660.1560.2470.2131.2330.096000
Short Term Debt 1.3721.7522.6431.3041.3060.1560.3160.310.1540015.15150000
Tax Payables 0.6420.4840.6190.8510.3682.71400.2010.110.0621.55900.0640000
Deferred Revenue 000.563-0.778-0.1850-0.2710000-0.21300000
Other Current Liabilities 22,453.16917.748.9645.1257.7386.6146.5476.2577.3365.8022.051187.4274.7911.9630.090.060
Total Current Liabilities 22,463.86120.08112.2828.9119.96610.3087.1357.2797.6656.0193.857202.7921.0882.0590.090.060
Non-Current Liabilities:
Long Term Debt 1.4581.9362.0222.3572.50.0130.0530.0910.12900000000
Deferred Revenue Non-Current 00000000000000000
Deferred Tax Liabilities Non-Current 00000000000000000
Other Non-Current Liabilities 2,076.8240.6950.5420.4630.5830.2550.3240.3140.2820.0050.0194.0250.244.0254.0254.0250
Total Non-Current Liabilities 2,078.2822.6312.5642.823.0830.2680.3770.4050.4110.0050.0194.0250.244.0254.0254.0250
Total Liabilities 24,542.14322.71214.84611.73113.04910.5777.5117.6858.0776.0243.876206.81521.3276.0844.1154.0850
Equity:
Preferred Stock 000000000000.0720.0720.072000
Common Stock 0.0060.0060.0060.0060.0060.0060.0060.0050.0050.0050.0050.0010.039115107.255107.4080
Retained Earnings -235,592.989-189.988-154.598-130.331-116.657-109.22-99.794-89.655-80.65-68.788-58.678-9.763-53.644-4.837-0.319-0.1670
Accumulated Other Comprehensive Income/Loss 4.9972.8343.2572.6932.3582.8750.0350.340.3510.2450.1340.098-0.1680000
Other Total Stockholders Equity 682,412.988675.343671.999670.185609.969531.272589.55131.309129.192123.826122.05434.15742.05605.3195.1670
Total Shareholders Equity 446,825.002488.195520.664542.554495.676424.933489.79741.99948.89855.28863.51524.395-11.645110.163112.255112.4070
Total Equity 446,831.568495.502530.031552.386513.491489.642499.1159.11268.76782.56894.55824.395-11.645110.163112.255112.4070
Total Liabilities & Shareholders Equity 477,933.282518.213544.878564.117526.54500.219506.62166.79776.84388.59298.434231.219.682116.247116.37116.4920